Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon.

"Declarations Ethics approval and consent to participateThe study was designed and conducted in accordance with the guidelines outlined in the World Medical Association Declaration of Helsinki. The Institutional Review Board (IRB) of the assigned hospital granted approval for the study's protocol (No. #01-22). To safeguard patients' privacy and confidentiality, their medical records were anonymized and de-identified. The research team maintained no direct contact or follow-up with the patients. Given the retrospective observational nature of the study, where data collection occurred after patients' discharge or death, and given that no patient identifiers were accessed, the IRB waived the need for informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests and no affiliation with any organization with a financial interest in the subject matter discussed in the manuscript. Competing interests The authors declare that they have no competing interests and no affiliation with any organization with a financial interest in the subject matter discussed in the manuscript."

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."